Zoetis, Inc. (ZTS)
69.69
+0.59
(+0.85%)
USD |
NYSE |
Oct 02, 16:00
69.27
-0.42
(-0.60%)
Pre-Market: 20:00
Zoetis Market Cap : 28.86B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 28.86B |
| October 01, 2026 | 28.62B |
| September 30, 2026 | 28.92B |
| September 29, 2026 | 29.12B |
| September 28, 2026 | 29.58B |
| September 25, 2026 | 29.43B |
| September 24, 2026 | 29.10B |
| September 23, 2026 | 29.66B |
| September 22, 2026 | 30.18B |
| September 21, 2026 | 29.54B |
| September 18, 2026 | 29.57B |
| September 17, 2026 | 30.24B |
| September 16, 2026 | 30.23B |
| September 15, 2026 | 30.41B |
| September 14, 2026 | 30.51B |
| September 11, 2026 | 30.22B |
| September 10, 2026 | 30.18B |
| September 09, 2026 | 30.36B |
| September 08, 2026 | 30.47B |
| September 04, 2026 | 31.40B |
| September 03, 2026 | 31.60B |
| September 02, 2026 | 31.55B |
| September 01, 2026 | 31.99B |
| August 31, 2026 | 31.93B |
| August 28, 2026 | 32.03B |
| Date | Value |
|---|---|
| August 27, 2026 | 31.07B |
| August 26, 2026 | 32.11B |
| August 25, 2026 | 32.01B |
| August 24, 2026 | 31.96B |
| August 21, 2026 | 32.19B |
| August 20, 2026 | 31.07B |
| August 19, 2026 | 31.76B |
| August 18, 2026 | 30.63B |
| August 17, 2026 | 30.22B |
| August 14, 2026 | 30.56B |
| August 13, 2026 | 31.41B |
| August 12, 2026 | 30.46B |
| August 11, 2026 | 31.21B |
| August 10, 2026 | 30.99B |
| August 07, 2026 | 30.09B |
| August 06, 2026 | 32.00B |
| August 05, 2026 | 30.81B |
| August 04, 2026 | 31.49B |
| August 03, 2026 | 32.41B |
| July 31, 2026 | 32.49B |
| July 30, 2026 | 31.96B |
| July 29, 2026 | 32.76B |
| July 28, 2026 | 32.58B |
| July 27, 2026 | 32.33B |
| July 24, 2026 | 31.67B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.076T |
| Merck & Co., Inc. | 356.23B |
| Elanco Animal Health, Inc. | 11.06B |
| Pfizer Inc. | 158.43B |
| Johnson & Johnson | 616.58B |
Market Cap Related Metrics
| PE Ratio | 11.46 |
| PS Ratio | 3.152 |
| PEG Ratio | 2.109 |
| Price to Book Value | 9.168 |
| Price to Free Cash Flow | 12.68 |
| Price | 69.69 |
| Earnings Yield | 8.72% |
| PEGY Ratio | 1.359 |
| Operating PE Ratio | 8.373 |
| Normalized PE Ratio | 11.09 |